Lataa...
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
After the genome sequence of SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) was published and the number of infected people began to increase rapidly, many global companies began to develop a vaccine. Almost all known approaches to vaccine design were applied for this purpose,...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
2020-12-01
|
| Sarja: | Vavilovskij Žurnal Genetiki i Selekcii |
| Aiheet: | |
| Linkit: | https://vavilov.elpub.ru/jour/article/view/2824 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|